1. Others

Others

There are a number of inhibitors, agonists, and antagonists which we cannot make precise classification because the research area is still unknown.

Others Related Products (73763):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-W353469
    2-O-(α-D-Glucopyranosyl)glycerol (55% in water) 22160-26-5 99.79%
    2-O-(α-D-Glucopyranosyl) glycerol (55% in water) (Glucosylglycerol) is a glycerol glycoside and compatible solute. 2-O-(α-D-Glucopyranosyl) glycerol is isolable from the marine cyanobacterium Oscillatoria sp. 2-O-(α-D-Glucopyranosyl) glycerol (55% in water) acts as a salt stress protectant in Synechocystis sp. PCC 6803 ΔggpS cells. It enhances salt tolerance of Synechocystis sp. PCC 6803 ΔggpS cells and maintains cell division under salt stress.
    2-O-(α-D-Glucopyranosyl)glycerol (55% in water)
  • HY-W410104
    4-Hydroxy-N,N,2-trimethyl-1H-benzimidazole-6-carboxamide 2168520-25-8 99.80%
    4-Hydroxy-N,N,2-trimethyl-1H-benzimidazole-6-carboxamide is a drug intermediate for synthesis of various active compounds.
    4-Hydroxy-N,N,2-trimethyl-1H-benzimidazole-6-carboxamide
  • HY-W442377
    (S)-2-(3-Bromophenyl)propanoic acid 1146411-14-4 98.30%
    (S)-2-(3-Bromophenyl)propanoic acid is a drug intermediate for synthesis of various active compounds.
    (S)-2-(3-Bromophenyl)propanoic acid
  • HY-W460072
    tert-Butyl 7-hydroxyheptanoate 86013-78-7 98.66%
    tert-Butyl 7-hydroxyheptanoate is a linker with a hydroxyl group and a t-butyl ester. The hydroxyl group allows for further derivatization or replacement with many other reactive functional groups. The t-butyl protected carboxyl group can be deprotected under acidic conditions.
    tert-Butyl 7-hydroxyheptanoate
  • HY-W587907
    5-Formylcytidine 148608-53-1
    5-Formylcytosine is a pyrimidine nitrogen base derived from cytosine.
    5-Formylcytidine
  • HY-W727879
    Upadacitinib-15N,d2 99.99%
    Upadacitinib-15N,d2 (ABT-494-15N,d2) is the deuterium-labeled Upadacitinib (HY-19569). Upadacitinib-15N,d2 (ABT-494) is a potent, orally active and selective Janus kinase 1 (JAK1) inhibitor (IC50=43 nM). Upadacitinib-15N,d2 (ABT-494) displays approximately 74 fold selective for JAK1 over JAK2 (200 nM) in cellular assays dependent on specific, relevant cytokines. Upadacitinib-15N,d2 (ABT-494) can be used for several autoimmune disorders research.
    Upadacitinib-15N,d2
  • HY-W010981S
    Acetyl tributyl citrate-d3 1794753-49-3 99.78%
    Acetyl tributyl citrate-d3 (Tributyl O-acetylcitrate-d3) is the deuterium labeled Acetyl tributyl citrate (HY-W010981). Acetyl tributyl citrate can be used in cosmetics, food packaging, and as a flavoring substance for food.
    Acetyl tributyl citrate-d3
  • HY-W077686A
    (R)-2-(Thiazol-2-yl)but-3-yn-2-ol 1202769-72-9 99.08%
    (R)-2-(Thiazol-2-yl)but-3-yn-2-ol is a drug intermediate for synthesis of various active compounds.
    (R)-2-(Thiazol-2-yl)but-3-yn-2-ol
  • HY-Y0261AS1
    Ammonium sulphate,≥99.0%,AR-N152 43086-58-4 99.30%
    Ammonium sulphate,≥99.0%,AR-15N2 is the deuterium labeled Ammonium sulphate,≥99.0%,AR. Ammonium sulphate,≥99.0%,AR is an inorganic sulfate salt used for molecular biology.
    Ammonium sulphate,≥99.0%,AR-N152
  • HY-W013940S1
    DL-Cystine-d6 352431-53-9 99.96%
    DL-Cystine-d6 is the deuterium labeled DL-Cystine (HY-W013940). DL-Cystine is a cysteine derivative.
    DL-Cystine-d6
  • HY-W012722BS1
    4-Methyl-2-oxopentanoic acid-13C sodium 93523-70-7 99.75%
    4-Methyl-2-oxopentanoic acid-13C (sodium) is the 13C labeled 4-Methyl-2-oxopentanoic acid sodium.
    4-Methyl-2-oxopentanoic acid-13C sodium
  • HY-12751A
    Trimethobenzamide hydrochloride 554-92-7 99.87%
    Trimethobenzamide hydrochloride is a blocker of the D2 receptor. Trimethobenzamide is an antiemetic used to prevent nausea and vomiting.
    Trimethobenzamide hydrochloride
  • HY-132382S
    β-Sitosterol-d7 (mixture of diasteromers) 2260669-28-9 98.0%
    β-Sitosterol-d7 (Mixture of Diastereomers) is the deuterium labeled β-Sitosterol (mixture of diasteromers).
    β-Sitosterol-d7 (mixture of diasteromers)
  • HY-132436S
    4’-Hydroxy Flurbiprofen-d3 1189694-02-7 99.23%
    4’-Hydroxy Flurbiprofen-d3 is the deuterium labeled 4’-Hydroxy Flurbiprofen.
    4’-Hydroxy Flurbiprofen-d3
  • HY-100382
    FPTQ 864863-72-9 99.92%
    FPTQ is potent mGluR1 antagonist with IC50 values of 6 nM and 1.4 nM for human and mouse mGluR1 respectively. FPTQ has anti-oxidant and anti-inflammatory effects in vitro and in vivo.
    FPTQ
  • HY-161182
    uPSEM792 hydrochloride 2341841-08-3 99.94%
    uPSEM792 hydrochloride is a PSAM4-GlyR agonist.
    uPSEM792 hydrochloride
  • HY-104009A
    GSK2807 Trifluoroacetate 2245255-66-5 99.83%
    GSK2807 Trifluoroacetate is a potent, selective and SAM-competitive inhibitor of SMYD3, with a Ki of 14 nM and an IC50 of 130 nM.
    GSK2807 Trifluoroacetate
  • HY-109152
    Navocaftor 2159103-66-7 99.20%
    Navocaftor (GLPG 3067), as a cystic fibrosis transmembrane regulator (CFTR), is a protein modulator (US 20200377491 Al, example 1).
    Navocaftor
  • HY-109191
    Sovesudil 1333400-14-8 99.91%
    Sovesudil (PHP-201) is a potent, ATP-competitive, locally acting Rho kinase (ROCK) inhibitor with IC50s of 3.7 and 2.3 nM for ROCK-I and ROCK-II, respectively. Sovesudil lowers intraocular pressure (IOP) without inducing hyperemia.
    Sovesudil
  • HY-148130
    Rugonersen 2591587-57-2 98.50%
    Rugonersen (RG6091; RO7248824) is a locked-nucleic acid (LNA)- modified antisense oligonucleotides (ASOs), and results in reduction of ubiquitin-protein ligase E3A (UBE3A) silencing. Angelman syndrome (AS) is a severe neurodevelopmental disorder caused by the loss of neuronal E3 ligase UBE3A, Rugonersen has been used for AS reasearch.
    Rugonersen